Pimitespib + Imatinib
NCT05245968
Taiho Pharmaceutical · Phase 1 · Active, not recruiting · Enrollment 78
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.
GIST
Programs, trials, and reported response and survival for gastrointestinal stromal tumor.
Pimitespib + Imatinib
Taiho Pharmaceutical · Phase 1 · Active, not recruiting · Enrollment 78
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.